Cannamedai S.A.
Other research and experimental development on natural sciences and engineering
Overview
Cannamedai is a company that specializes in the research and development of cannabis-based therapies, utilizing advanced AI algorithms to analyze large datasets from cannabis research. It focuses on improving the health outcomes of oncology patients by personalizing cannabis treatments to meet individual patient needs. The company collaborates with scientists, doctors, and regulators to ensure its innovations are scientifically validated and compliant with regulations.
Financials
Revenue history (in k)
Filing timeliness
No financial statement for 2024 – the filing deadline has passed. 2 of 2 financial statements were filed late (the longest delay 391 days for 2022).
- 2024not filed
- 202316/01/2025
- 202209/08/2024
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2023.
Results vs industry
Industry
Offer
- Research into cannabis-based therapies
- Medical data analysis
- Development of cannabis-based therapies
- Personalised therapy
- Cannabis-based medical products
Websites
- cannamedai.comCannamedai S.A. – klinika konopi medycznych oparta na AIWordPress 3.7ElementorLLiteSpeed
Authorized Representatives
Manner of representation
The company is represented by: 1. in the case of a one-person management board – the sole member of the management board acting independently. 2. in the case of a management board consisting of more than one person – two members of the management board jointly, or one member of the management board jointly with a commercial proxy. 3. The management board may incur obligations on behalf of the company or dispose of a right with a value not exceeding PLN 500,000.00 (five hundred thousand zlotys). Above this amount, it must obtain the consent of the supervisory board.
Supervisory board
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Was a VAT taxpayer from 2022-02-15 to 2026-01-21.
Reason for removal: Art. 96 ust. 9a pkt 3 (VAT returns showing no transactions filed for 6 consecutive months or 2 quarters)
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Biostat Research and Development sp. z o.o. | $50,225.77 | biostat.com.pl | ||
| Personather sp. z o.o. | $47,478.47 | personather.pl | ||
| Zawamed sp. z o.o. | $43,909.06 | zawamed.pl | ||
| Orphinic Scientific S.A. | $42,972.42 | orphinic.com | ||
| Onconick sp. z o.o. | $39,587.95 | onconick.com | ||
| Biolabic sp. z o.o. | $37,688.85 | biolabic.pl | ||
| DR Joanna Sanford sp. k. | $28,674.82 | sanfordbiotech.com | ||
| Inventro S.A. | $25,971.59 | inventro.co | ||
| Nanovelos S.A. | $24,842.03 | nanovelos.com | ||
| Emotin sp. z o.o. | $18,688.59 | emotin.pl |
Change history
| Date | Event | |
|---|---|---|
| 2024-06-11 | Address change (Ul. Bartosza Głowackiego 25-27/8a, 45-110, Opole → Ul. Bartosza Głowackiego 25-27/8c, 45-110, Opole) | |
| 2024-06-11 | Name change (Konopie.pl → Cannamedai) | |
| 2024-06-11 | PKD change (Removed: 7 codes; Added: 7 codes) | |
| 2024-02-29 | Address change (Ul. Ozimska 38/2a, 45-058, Opole → Ul. Bartosza Głowackiego 25-27/8a, 45-110, Opole) | |
| 2022-05-16 | Address change (Ul. Sieradzka 17/36, 45-304, Opole → Ul. Ozimska 38/2a, 45-058, Opole) |
FAQ
Last updated: 2026-04-01